- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Auditory; Nerve in Australia
Total 605 results
-
Societe Internationale d'Oncologie PediatriqueChildren's Cancer and Leukaemia GroupCompletedNeuroblastomaSwitzerland, Spain, Germany, Belgium, France, Denmark, Austria, Italy, Norway, Portugal, Sweden, United Kingdom
-
Bristol-Myers SquibbCompletedMelanomaItaly, Netherlands, Russian Federation, Czechia, Hungary, Ireland, Norway, Spain, Switzerland, Austria, Germany, Denmark, France, Belgium, United Kingdom, United States
-
AstraZenecaCompletedRefractory MelanomaUnited States, Spain, Canada, France, Italy, United Kingdom, Argentina, Australia, Germany
-
Gustave Roussy, Cancer Campus, Grand ParisCompletedRefractory Low-grade Gliomas | Recurrent Low-grade GliomasAustria, Italy, France, Denmark, Netherlands, Spain, Switzerland, United Kingdom
-
Gustave Roussy, Cancer Campus, Grand ParisInnovative Therapies For Children with Cancer ConsortiumTerminatedRefractory Low-grade Gliomas | Recurrent Low-grade GliomasAustria, Italy, France, Denmark, Netherlands, Spain, Switzerland, United Kingdom
-
AmgenCompletedCompletely Resectable Stage IIIB, IIIC, or IVM1a MelanomaUnited States, Poland, France, Russian Federation, Spain, Australia, Greece, Switzerland, Brazil
-
Novartis PharmaceuticalsCompletedCancerFrance, Australia, United States, Canada, United Kingdom
-
Novartis PharmaceuticalsCompletedMelanomaCanada, Spain, United Kingdom, Netherlands, United States, Argentina, Australia, France, Germany, Greece, Italy, Russian Federation, Sweden, Ukraine
-
Genta IncorporatedCompletedMelanomaUnited States, France, United Kingdom, Spain, Switzerland, Australia, Canada, Germany, Poland, Italy, Austria, Czech Republic
-
Bristol-Myers SquibbNektar TherapeuticsCompletedMelanomaCanada, Australia, France, Italy, Brazil, United States, Argentina, Austria, Belgium, Chile, Czechia, Finland, Germany, Greece, Ireland, Israel, Mexico, Netherlands, New Zealand, Poland, Portugal, Romania, Russian Federation, Spain, Sweden and more
-
Eli Lilly and CompanyTerminatedMelanomaUnited States, Italy, Australia, Spain, France, Netherlands, United Kingdom, Austria, Poland, Germany, Belgium, Taiwan, Canada, Finland, Israel, Korea, Republic of, Norway, Sweden
-
Hoffmann-La RocheTerminatedMalignant MelanomaUnited States, France, Australia, United Kingdom, Italy, Spain, Germany, Israel, Poland, Slovakia
-
Eli Lilly and CompanyActive, not recruitingGlioblastomaUnited States, Germany, Spain, Belgium, Italy, Australia, Canada, France, Poland
-
EusaPharma (UK) LimitedUnited BioSource, LLCRecruitingNeuroblastomaFrance, Germany, United Kingdom, Italy, Austria, Poland, Spain
-
European Organisation for Research and Treatment...CompletedGlioblastomaFrance, Germany, Netherlands, Switzerland, Greece, United States, Austria, Belgium, Italy
-
Hoffmann-La RocheCompletedGlioblastomaUnited States, United Kingdom, Belgium, Denmark, Korea, Republic of, Poland, Spain, Canada, Sweden, Russian Federation, Australia, Greece, Portugal, France, Netherlands, New Zealand, Switzerland, Germany, Hong Kong, Hungary, Israel and more
-
Philogen S.p.A.Immatics Biotechnologies GmbHTerminatedMerkel Cell CarcinomaGermany, Austria, Denmark, France, Spain, United Kingdom
-
Pierre Fabre MedicamentEuropean Organisation for Research and Treatment of Cancer - EORTCActive, not recruitingMelanomaSpain, Canada, Hungary, Italy, Belgium, Netherlands, Australia, Czechia, Greece, Brazil, Portugal, Serbia, Sweden, Norway, Germany, Argentina, Romania, Poland, United Kingdom, Austria, Switzerland, France, South Africa
-
Hoffmann-La RocheActive, not recruitingMelanomaUnited States, Korea, Republic of, United Kingdom, Australia, France, Belgium, Italy, Portugal, Spain, Brazil, Canada, Russian Federation, Germany, New Zealand, Israel, Poland, Greece, Austria, Hungary, Netherlands
-
CelgeneUniversity of ArizonaCompletedMalignant MelanomaCanada, United States, Australia, United Kingdom, France, Italy, Spain, Germany, Netherlands
-
Novartis PharmaceuticalsCompletedRecurrent Glioblastoma MultiformeUnited States, Belgium, Australia, Spain, France, Canada
-
European Organisation for Research and Treatment...UnknownMelanoma (Skin)France, Spain, United Kingdom, Belgium, Australia, Poland, Germany, Netherlands, Slovenia, Italy, Switzerland, Israel, Bulgaria, Croatia, Czech Republic, Estonia, Portugal, Turkey
-
Bristol-Myers SquibbActive, not recruitingA Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced CancersMelanoma | CancerUnited States, Poland, Italy, Belgium, France, Australia, Canada, Germany, Spain, Sweden, Switzerland, United Kingdom
-
Santhera PharmaceuticalsCompletedLeber's Hereditary Optic Neuropathy (LHON)Italy, Germany, France, Austria, Greece, Netherlands
-
Melanoma and Skin Cancer Trials LimitedNorfolk and Norwich University Hospitals NHS Foundation Trust; Peter MacCallum...Active, not recruitingCutaneous Melanoma by AJCC V7 StageUnited Kingdom, United States, Sweden, Australia, Canada
-
Novartis PharmaceuticalsCompletedRecurrent Glioblastoma or Other Glioma SubtypesSpain, Belgium, United States, Switzerland, Australia, Netherlands
-
Bristol-Myers SquibbActive, not recruitingUnresectable or Metastatic MelanomaUnited States, France, Poland, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, Germany, Ireland, Israel, Italy, Netherlands, New Zealand, Norway, Spain, Sweden, Switzerland, United Kingdom, Russian Federation
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, Belgium, Canada, Spain, United Kingdom, Netherlands, Argentina, Australia, Austria, Brazil, Czechia, Denmark, France, Germany, Greece, Israel, Italy, Japan, New Zealand, Norway, Poland, Russian Federation, Sweden, Switz... and more
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, United Kingdom, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand, United Kingdom
-
Alexion PharmaceuticalsTerminatedNeuromyelitis Optica | Neuromyelitis Optica Spectrum DisorderHong Kong, United States, United Kingdom, Croatia, Malaysia, Korea, Republic of, Turkey, Japan, Italy, Spain, Taiwan, Australia, Argentina, Thailand, Russian Federation, Czechia, Denmark, Germany
-
European Organisation for Research and Treatment...CompletedBrain and Central Nervous System TumorsNetherlands, Germany, Italy, France, Austria, Canada
-
Bristol-Myers SquibbActive, not recruitingMelanomaUnited States, Italy, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Czechia, Denmark, Finland, France, Germany, Greece, Israel, Mexico, Norway, Romania, Spain, Sweden, Switzerland, United Kingdom
-
Alexion PharmaceuticalsCompletedNeuromyelitis Optica | Neuromyelitis Optica Spectrum DisorderHong Kong, Korea, Republic of, United States, Croatia, Australia, Canada, Malaysia, Japan, Italy, Turkey, Spain, Taiwan, Argentina, Colombia, Czechia, Denmark, Germany, Russian Federation, Thailand, United Kingdom
-
GlaxoSmithKlineCompletedMelanoma and Brain MetastasesAustralia, Germany, United States, Canada, Italy, France
-
Bristol-Myers SquibbCompletedAdvanced Cutaneous MelanomaGermany, Poland, Spain, Australia, France, Argentina, Ireland, Israel, Belgium, United States, Switzerland, United Kingdom, Greece, Austria, Canada
-
European Organisation for Research and Treatment...CompletedMelanoma (Skin)France, Switzerland, Germany, Belgium, Netherlands, United Kingdom, Italy, Portugal, Austria
-
St. Jude Children's Research HospitalCompletedBrain and Central Nervous System TumorsUnited States, Australia, Canada
-
AmgenMerck Sharp & Dohme LLCCompletedMelanomaUnited States, Canada, Spain, France, Australia, Greece, Italy, United Kingdom, Germany, Netherlands, Poland
-
PfizerCompletedMelanomaUnited States, Australia, Canada, Germany, Italy, Netherlands, Spain, Switzerland, United Kingdom
-
AstraZenecaCompletedMelanomaUnited States, Italy, Spain, Sweden, Belgium, Canada, Poland, Switzerland, France, Russian Federation, United Kingdom, Australia, Argentina, Germany, Netherlands, Israel, South Africa, Austria, Greece, Mexico, Slovakia
-
Synta Pharmaceuticals Corp.TerminatedMelanomaUnited States, Spain, Canada, Australia, Germany, Puerto Rico, Romania, United Kingdom
-
Bristol-Myers SquibbActive, not recruitingMelanomaItaly, Poland, United States, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Germany, Greece, Netherlands, Norway, Romania, Spain, Switzerland, United Kingdom, Sweden
-
Insel Gruppe AG, University Hospital BernEuropean Organisation for Research and Treatment of Cancer - EORTCRecruitingGlioblastomaGermany, Switzerland, Austria, Greece, Italy, Portugal, Romania
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, United Kingdom, Austria, Belgium, Hungary, Canada, Netherlands, Argentina, Australia, Brazil, Czechia, Denmark, France, Germany, Israel, Italy, Norway, Poland, Russian Federation, Spain, Switzerland, Taiwan, Korea, Republic... and more
-
Bristol-Myers SquibbActive, not recruitingRecurrent GlioblastomaPoland, United Kingdom, United States, Spain, Australia, Germany, Italy, Denmark, Belgium, France, Netherlands, Switzerland
-
Bristol-Myers SquibbCompletedHigh Risk Stage III MelanomaItaly, Poland, United Kingdom, United States, Netherlands, Spain, Australia, France, Germany, Canada, Russian Federation, Belgium, Norway, Switzerland, Sweden, Finland, Austria, Denmark, Czechia
-
Bristol-Myers SquibbCompletedMelanomaBrazil, Chile, United States, Ireland, Italy, Spain, Argentina, Australia, Canada, France, Mexico, New Zealand, Poland, Romania
-
Santhera PharmaceuticalsCompletedLeber's Hereditary Optic Neuropathy (LHON)United States, United Kingdom, Spain, Poland, Austria, Belgium, Bulgaria, Germany, Italy, Portugal
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingMalignant MelanomaUnited States, Australia, Austria, Brazil, Canada, Chile, China, France, Germany, Israel, Italy, Korea, Republic of, Poland, South Africa, Spain, Sweden, Switzerland, United Kingdom